Pharmaceutical Excipients Global Market
Date: 4/27/2015 Pharmaceutical Excipients Market by Products (Organic chemicals, Inorganic Chemicals), Functionality (Fillers, Binders, Lubricants, Preservatives), & by Route of Administration (Oral, Topical, Parenteral, Others) – Global Forecast to 2019 The global pharmaceutical excipients market is segmented by product, functionality, route of administration, and geography. By product, the pharmaceutical excipients market is broadly classified into organic chemicals, and inorganic chemicals. The organic chemicals market is further sub-segmented into carbohydrates, proteins, oleo chemicals and petrochemicals, and proteins. The inorganic chemicals market covers calcium products, halite, and metal oxides. By functionality, the pharmaceutical excipients market is classified into fillers and diluents, binders, suspension and viscosity agents, coatings, flavoring agents, disintegrate, colorants, lubricants and glidants, preservatives, and other applications. The total market is further divided into four major geographies, namely, North America, Europe, Asia, and the Rest of the World (RoW). These regions are further analyzed at the country level. The present report also discusses the key market drivers, restraints, opportunities and challenges of the global pharmaceutical excipients market and its sub-markets. The global pharmaceutical excipients market is dominated by North America, followed by Europe, and Asia-Pacific. Overall, the Asia-Pacific region is expected to witness the highest growth due to increasing number of companies outsourcing their excipient manufacturing activities to countries such as India and China due to low manufacturing and labor costs in these countries. North America and Europe are expected to grow at a sluggish rate, since these are relatively saturated markets. The major players in the pharmaceutical excipients market include Ashland Inc. (U.S.), BASF SE (Garmany), The Dow Chemical Company (U.S.), Roquette (France), Colorcon, Inc. (U.S.), Avantor Performance Materials, Inc. (U.S.), FMC Corporation (U.S.), Evonik Industries (Germany), and Lubrizol Corporation (U.S.). ###
The global pharmaceutical excipients market is estimated to grow at a CAGR of 6.7% from 2014 to 2019. Growing demand of functional excipients, patent cliffs increasing the demand of generics, and emergence of new excipients in the market are the major factors driving the growth of the pharmaceutical excipients market. The pharmaceutical industry is witnessing a gradual shift towards adoption of nanotechnology which helps impart new functions to pharmaceutical excipients. Such products have enabled targeting the disease site more specifically, resulting in reduced drug toxicity, a major challenge faced by the pharmaceutical industry. Nanotechnology-enabled drug delivery systems (NDDS) and liposomal drug delivery systems are some of the advanced drug delivery systems under focus. However, declining investments in R&D by pharmaceutical excipients producers, and increasing regulatory requirements leading to scarcity of U.S. FDA approved manufacturing sites are some of the major factors that could weaken the growth of this market to a certain extent.
AIS’s Industrial HMIs provide pharmaceutical, biotechnology and life sciences companies with strict regulatory adherence requirements, an operating and monitoring HMI solution that will help visualize and solve environmental monitoring systems, building management systems, manufacturing, processing and packaging equipment and business automation systems such as MES, laboratory and IT.